4-oxo-2-nonenal has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Kabbani, O; Endo, S; Hara, A; Hojo, A; Matsunaga, T; Yamane, Y | 1 |
1 other study(ies) available for 4-oxo-2-nonenal and Colonic Neoplasms
Article | Year |
---|---|
Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldehydes; Aldo-Keto Reductase Family 1 Member C3; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Resistance, Neoplasm; HeLa Cells; HT29 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; MCF-7 Cells; Oxidative Stress; Proteasome Endopeptidase Complex | 2013 |